AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

PRUCALOPRIDE 2 Mg ;

11 registrations across 1 African market— 11 active

Markets with PRUCALOPRIDE 2 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Constinon 2 mg
Film Coated Tablets
🇪🇬Egyptorgano for pharmaceutical and chemical industries (organo pharma)active
Lassativopride 2 mg
Film Coated Tablets
🇪🇬EgyptSouth Egypt Drug Industries Co (SEDICO)active
Prucanetic 2mg
Film Coated Tablets
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Lassativopride 2 mg
Film Coated Tablets
🇪🇬EgyptSouth Egypt Drug Industries Co (SEDICO)active
Prucanetic 2mg
Film Coated Tablets
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Pridemark
Film Coated Tablets
🇪🇬EgyptCare Mark Pharmaactive
Conistova 2 mg
Film Coated Tablets
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
Resolor
Film Coated Tablets
🇪🇬EgyptChemipharm Limited for trading and distributionactive
Pridemark
Film Coated Tablets
🇪🇬EgyptCare Mark Pharmaactive
Prucasoft 2 mg
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Resolor
Film Coated Tablets
🇪🇬EgyptChemipharm Limited for trading and distributionactive

PRUCALOPRIDE 2 Mg ; in Africa — Regulatory Overview

PRUCALOPRIDE 2 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.